Terms: = Kidney tumors AND BMPR1A, ACVRLK3, 657, ENSG00000107779, P36894, ALK3, CD292 AND Treatment
12 results:
1. Cytoplasmic Expression of AXL Is Associated With High Risk of Postoperative Relapse of Conventional Renal Cell Carcinoma.
Peterfi L; Bjercke T; Yusenko MV; Kovacs G; Banyai D
Anticancer Res; 2020 Jun; 40(6):3485-3489. PubMed ID: 32487648
[TBL] [Abstract] [Full Text] [Related]
2. Current status and treatment modalities in metastases to the pituitary: a systematic review.
Ng S; Fomekong F; Delabar V; Jacquesson T; Enachescu C; Raverot G; Manet R; Jouanneau E
J Neurooncol; 2020 Jan; 146(2):219-227. PubMed ID: 31933258
[TBL] [Abstract] [Full Text] [Related]
3. Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study).
Schmidinger M; Bamias A; Procopio G; Hawkins R; Sanchez AR; Vázquez S; Srihari N; Kalofonos H; Bono P; Pisal CB; Hirschberg Y; Dezzani L; Ahmad Q; Jonasch E;
Oncologist; 2019 Apr; 24(4):491-497. PubMed ID: 30867244
[TBL] [Abstract] [Full Text] [Related]
4. Baseline Edmonton Symptom Assessment System and survival in metastatic renal cell carcinoma.
Graham J; Gingerich J; Lambert P; Alamri A; Czaykowski P
Curr Oncol; 2018 Aug; 25(4):e319-e323. PubMed ID: 30111978
[TBL] [Abstract] [Full Text] [Related]
5. Age is not a prognostic factor in children with Wilms tumor beyond stage I in Africa.
Aronson DC; Hadley GP
Pediatr Blood Cancer; 2014 Jun; 61(6):987-9. PubMed ID: 24453084
[TBL] [Abstract] [Full Text] [Related]
6. [Free fatty acids induce proliferation of human renal carcinoma 786-O cell line via integrin-linked kinase].
Liu ZH; Xie J; Xiao YB; Yuan YQ; Zhang XW; Qin CP; Hao YC; Xu T; Wang XF
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):217-20. PubMed ID: 23591340
[TBL] [Abstract] [Full Text] [Related]
7. External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study.
Heng DY; Xie W; Regan MM; Harshman LC; Bjarnason GA; Vaishampayan UN; Mackenzie M; Wood L; Donskov F; Tan MH; Rha SY; Agarwal N; Kollmannsberger C; Rini BI; Choueiri TK
Lancet Oncol; 2013 Feb; 14(2):141-8. PubMed ID: 23312463
[TBL] [Abstract] [Full Text] [Related]
8. Progression free survival of first line vascular endothelial growth factor-targeted therapy is an important prognostic parameter in patients with metastatic renal cell carcinoma.
Seidel C; Busch J; Weikert S; Steffens S; Fenner M; Ganser A; Grünwald V
Eur J Cancer; 2012 May; 48(7):1023-30. PubMed ID: 22436979
[TBL] [Abstract] [Full Text] [Related]
9. Multikinase inhibitors in metastatic renal cell carcinoma: indirect comparison meta-analysis.
Leung HW; Chan AL
Clin Ther; 2011 Jun; 33(6):708-16. PubMed ID: 21704235
[TBL] [Abstract] [Full Text] [Related]
10. [A pilot clinical trial of gemcitabine and capecitabine chemotherapy for the treatment of advanced renal cell carcinoma failing immunotherapy].
Kobayashi M; Nakano K; Ikeda H; Nukui A; Suzuki K; Sugaya Y; Yuzawa M; Morita T
Gan To Kagaku Ryoho; 2008 Feb; 35(2):277-9. PubMed ID: 18281765
[TBL] [Abstract] [Full Text] [Related]
11. Infusional floxuridine-based therapy for patients with metastatic renal cell carcinoma.
Reese DM; Corry M; Small EJ
Cancer; 2000 Mar; 88(6):1310-6. PubMed ID: 10717611
[TBL] [Abstract] [Full Text] [Related]
12. Late effects of cisplatin-based chemotherapy on renal function in patients with ovarian carcinoma.
Markman M; Rothman R; Hakes T; Reichman B; Lewis JL; Rubin S; Jones W; Almadrones L; Hoskins W
Gynecol Oncol; 1991 Jun; 41(3):217-9. PubMed ID: 1869097
[TBL] [Abstract] [Full Text] [Related]
